0001104659-22-095384.txt : 20220829 0001104659-22-095384.hdr.sgml : 20220829 20220829083025 ACCESSION NUMBER: 0001104659-22-095384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220826 FILED AS OF DATE: 20220829 DATE AS OF CHANGE: 20220829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTOMARI ALFRED CENTRAL INDEX KEY: 0001285644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36464 FILM NUMBER: 221207310 MAIL ADDRESS: STREET 1: C/O AGILE THERAPEUTICS, INC. STREET 2: 101 POOR FARM ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC CENTRAL INDEX KEY: 0001261249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 BUSINESS PHONE: 609-683-1880 MAIL ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 4 1 tm2224680-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-26 0 0001261249 AGILE THERAPEUTICS INC AGRX 0001285644 ALTOMARI ALFRED 500 COLLEGE ROAD EAST, SUITE 310 PRINCETON NJ 08540 1 1 0 0 Chief Executive Officer Common Stock 2022-08-26 4 P 0 50000 0.45 A 64343 D The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4467 to $0.4498, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Geoffrey P. Gilmore, Attorney-In-Fact 2022-08-29